OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
87 hedge funds and large institutions have $175M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
41% less call options, than puts
Call options by funds: $1.86M | Put options by funds: $3.13M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
87
Holding in Top 10
1
Calls
$1.86M
Puts
$3.13M
Top Buyers
| 1 | +$5.14M | |
| 2 | +$5.13M | |
| 3 | +$1.99M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$1.85M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$1.49M |
Top Sellers
| 1 | -$20.9M | |
| 2 | -$2.53M | |
| 3 | -$1.57M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$1.09M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$464K |